NEXGEL, Inc. (NXGLW) stock
NXGLWNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NXGL
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026Score 6/3072% below fair value
$0.01+0.00 (0.00%)
Close on Oct 30, 2026Market cap $34.21MP/E –Yield –
Nexgel cash
Cash and short-term investments held at the end of each period.
Nexgel's cash was $492.00K at Jun 30, 2026. For fiscal 2025 it was $317.00K, down 82.5% from the year before. The highest annual figure on record is $13.35M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $317.00K | -82.5% |
| FY2024 | Dec 31, 2024 | $1.81M | -33.1% |
| FY2023 | Dec 31, 2023 | $2.70M | -59.1% |
| FY2022 | Dec 31, 2022 | $6.61M | -50.5% |
| FY2021 | Dec 31, 2021 | $13.35M | +41618.8% |
| FY2020 | Dec 31, 2020 | $32.00K | -87.7% |
| FY2019 | Dec 31, 2019 | $261.00K | – |
| FY2018 | Dec 31, 2018 | $0 | – |
| FY2017 | Dec 31, 2017 | $0 | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $492.00K | -32.1% |
| Q1 FY2026 | Mar 31, 2026 | $208.00K | -82.6% |
| Q4 FY2025 | Dec 31, 2025 | $317.00K | -82.5% |
| Q3 FY2025 | Sep 30, 2025 | $938.00K | -11.4% |
| Q2 FY2025 | Jun 30, 2025 | $725.00K | -32.2% |
| Q1 FY2025 | Mar 31, 2025 | $1.19M | -50.7% |
| Q4 FY2024 | Dec 31, 2024 | $1.81M | -33.1% |
| Q3 FY2024 | Sep 30, 2024 | $1.06M | -67.6% |
| Q2 FY2024 | Jun 30, 2024 | $1.07M | -75.2% |
| Q1 FY2024 | Mar 31, 2024 | $2.42M | -58.3% |
| Q4 FY2023 | Dec 31, 2023 | $2.70M | -59.1% |
| Q3 FY2023 | Sep 30, 2023 | $3.27M | -55.9% |
| Q2 FY2023 | Jun 30, 2023 | $4.30M | -56.1% |
| Q1 FY2023 | Mar 31, 2023 | $5.80M | -44.8% |
| Q4 FY2022 | Dec 31, 2022 | $6.61M | -50.5% |
| Q3 FY2022 | Sep 30, 2022 | $7.41M | +490.6% |
| Q2 FY2022 | Jun 30, 2022 | $9.79M | +2463.1% |
| Q1 FY2022 | Mar 31, 2022 | $10.52M | +883.2% |
| Q4 FY2021 | Dec 31, 2021 | $13.35M | +41618.8% |
| Q3 FY2021 | Sep 30, 2021 | $1.26M | +699.4% |
| Q2 FY2021 | Jun 30, 2021 | $382.00K | +63.9% |
| Q1 FY2021 | Mar 31, 2021 | $1.07M | +386.4% |
| Q4 FY2020 | Dec 31, 2020 | $32.00K | -87.7% |
| Q3 FY2020 | Sep 30, 2020 | $157.00K | +78.4% |
| Q2 FY2020 | Jun 30, 2020 | $233.00K | +25.3% |
| Q1 FY2020 | Mar 31, 2020 | $220.00K | – |
| Q4 FY2019 | Dec 31, 2019 | $261.00K | – |
| Q3 FY2019 | Sep 30, 2019 | $88.00K | – |
| Q2 FY2019 | Jun 30, 2019 | $186.00K | – |
| Q1 FY2019 | Mar 31, 2019 | $0 | – |
| Q4 FY2018 | Dec 31, 2018 | $0 | – |
| Q3 FY2018 | Sep 30, 2018 | $0 | – |
| Q2 FY2018 | Jun 30, 2018 | $0 | – |
| Q4 FY2017 | Dec 31, 2017 | $0 | – |